Excessive AT1 receptor stimulation is associated with brain inflammation, whereas stimulation of AT2 receptors has been proposed to exert balancing neuroprotective effects, particularly when AT1 receptors are blocked by ARB administration [43-45]. The gene discussed is AGTR1; the disease is inflammation.